New York, NY -- (SBWIRE) -- 01/03/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: -- Opko Health Inc.(NYSE:OPK), Hanwha Solarone Co Ltd(NASDAQ:HSOL), Golden Star Resources Ltd. (USA)(NYSEMKT:GSS), Idera Pharmaceuticals Inc(NASDAQ:IDRA)
Opko Health Inc.(NYSE:OPK) reported loss -0.36% and closed at $8.41 with the total traded volume of 4.27M shares. Its market capitalization is $3.43B. The stock has a 52-week high price of 12.95 and its 52-week low was recorded at $4.83
OPKO Health, Inc. (OPKO) is a multi-national pharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various condition
What OPK Charts Are Signaling for Traders? Find Out Here
Hanwha Solarone Co Ltd(NASDAQ:HSOL) gain 18.05% and ended at $3.27.The total traded volume was 4.28M shares and market capitalization arrived at $276.90M. The stock has a 52-week high price of $5.70 and its 52-week low was recorded at $0.86 while during last trade its minimum price was $2.82 and it gained the highest price of $3.28.
Hanwha SolarOne Co., Ltd. (Hanwha SolarOne) is an integrated manufacturer of silicon ingots, silicon wafers, PV cells and PV modules in China. The Company manufactures a range of silicon ingots, silicon wafers, Photovoltaic (PV) cells and PV modules using advanced manufacturing process technologies that have helped the Company to increase its operational efficiency.
Is HSOL Buy After The Recent Price Movement? Find Out Here
Golden Star Resources Ltd. (USA)(NYSEMKT:GSS)’s reported the increase of 11.36% to close at $0.490 with the overall traded volume of 4.24M shares. Its market capitalization on last close reached to $126.96 million. Its intraday-low price was $0.47 and its hit its day's highest price at $0.50.
Golden Star Resources Ltd, (Golden Star) is an international gold mining and exploration company producing gold in Ghana, West Africa.
Should GSS a Buy or Sell Now? Find Out Here
Idera Pharmaceuticals Inc(NASDAQ:IDRA) gain 2.59% settle at $4.75. Its total traded volume during last trading session was 4.05M shares. The overall market worth of this company is about $221.95M. The 52 week range of the stock remained $0.19 - $4.97, while its day's lowest price was $4.39 and its hit its day's highest price at $4.97.
Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates.
What IDRA Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)